Combination antifungal therapy

Same author

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Antimicrobial agents and chemotherapy·2026

Same author

Closing the gap on antifungal resistance.

Nature medicine·2026

Same author

Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus.

The Journal of antimicrobial chemotherapy·2026

Same author

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

The Journal of antimicrobial chemotherapy·2026

Same author

Multisystem Lomentospora prolificans progression on fosmanogepix despite in vitro activity: a call for expanding clinical research on novel antifungals.

ASM case reports·2026

Same author

Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patients.

Medical mycology·2026

Same journal

In vitro antibacterial activity of gepotidacin in combination with other antimicrobial agents against Neisseria gonorrhoeae isolates.

Antimicrobial agents and chemotherapy·2026

Same journal

Development of domain-specific probes of Plasmodium falciparum heat shock protein 70-1.

Antimicrobial agents and chemotherapy·2026

Same journal

Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.

Antimicrobial agents and chemotherapy·2026

Same journal

Indole-based hybrids target both asexual parasites and gametocytes of Plasmodium falciparum and synergize with lumefantrine.

Antimicrobial agents and chemotherapy·2026

Same journal

Lineage-specific loss of the type VI secretion system in Acinetobacter baumannii ST19 is associated with reduced accessory genome content.

Antimicrobial agents and chemotherapy·2026

Same journal

Genomic diversity and topical antimicrobial resistance in Staphylococcus aureus from clinical and carriage populations in the New York-New Jersey region.

Antimicrobial agents and chemotherapy·2026

Related Experiment Videos

Combination antifungal therapy

Related Concept Videos

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Closing the gap on antifungal resistance.

Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus.

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungals.

Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patients.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine.

Lineage-specific loss of the type VI secretion system in <i>Acinetobacter baumannii</i> ST19 is associated with reduced accessory genome content.

Genomic diversity and topical antimicrobial resistance in <i>Staphylococcus aureus</i> from clinical and carriage populations in the New York-New Jersey region.

Related Experiment Videos

Combination antifungal therapy

Related Concept Videos

Related Articles

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Closing the gap on antifungal resistance.

Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus.

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungals.

Rhino-sino-orbital and/or central nervous system infections due to Lomentospora prolificans and Scedosporium spp. in onco-haematology patients.

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine.

Lineage-specific loss of the type VI secretion system in <i>Acinetobacter baumannii</i> ST19 is associated with reduced accessory genome content.

Genomic diversity and topical antimicrobial resistance in <i>Staphylococcus aureus</i> from clinical and carriage populations in the New York-New Jersey region.